Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol-Remifentanil for Colonoscopy Sedation
NCT03925779Phase 2Completed
- Sponsor
- Menoufia University
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in conscious sedation, sponsored by Menoufia University. Primary endpoint: Sedation. Started Jun 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
conscious sedation
Beyond the preview
Go deeper on NCT03925779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03925779.